Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Cash from Operations (2017 - 2026)

Cogent Biosciences' Cash from Operations history spans 10 years, with the latest figure at 86883000.0 for Q1 2026.

  • Quarterly Cash from Operations fell 30.63% to 86883000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 284816000.0 through Mar 2026, down 28.43% year-over-year, with the annual reading at 264444000.0 for FY2025, 27.26% down from the prior year.
  • Cash from Operations came in at 86883000.0 for Q1 2026, down from 79105000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 26456000.0 in Q2 2022 to a low of 86883000.0 in Q1 2026.
  • The 5-year median for Cash from Operations is 44070000.0 (2023), against an average of 48904705.88.
  • Year-over-year, Cash from Operations crashed 149.29% in 2022 and then fell 10.25% in 2023.
  • Cogent Biosciences' Cash from Operations stood at 29408000.0 in 2022, then tumbled by 49.86% to 44070000.0 in 2023, then tumbled by 37.46% to 60577000.0 in 2024, then plummeted by 30.59% to 79105000.0 in 2025, then fell by 9.83% to 86883000.0 in 2026.
  • Per Business Quant, the three most recent readings for COGT's Cash from Operations are 86883000.0 (Q1 2026), 79105000.0 (Q4 2025), and 64286000.0 (Q3 2025).